DETTI, BEATRICE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.832
AS - Asia 1.658
EU - Europa 1.206
SA - Sud America 158
AF - Africa 42
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 22
Totale 4.943
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.767
RU - Federazione Russa 548
CN - Cina 537
SG - Singapore 465
IT - Italia 261
HK - Hong Kong 218
KR - Corea 167
BR - Brasile 119
VN - Vietnam 108
IE - Irlanda 82
FR - Francia 77
DE - Germania 69
SE - Svezia 45
FI - Finlandia 44
IN - India 42
CA - Canada 40
GB - Regno Unito 29
JO - Giordania 26
AU - Australia 24
ID - Indonesia 18
BD - Bangladesh 14
NL - Olanda 11
AR - Argentina 10
TR - Turchia 10
IQ - Iraq 9
EC - Ecuador 8
JP - Giappone 8
NG - Nigeria 8
ES - Italia 7
PL - Polonia 7
ZA - Sudafrica 6
CO - Colombia 5
MX - Messico 5
SA - Arabia Saudita 5
TN - Tunisia 5
UY - Uruguay 5
CL - Cile 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
LY - Libia 4
MA - Marocco 4
UA - Ucraina 4
BY - Bielorussia 3
CI - Costa d'Avorio 3
EG - Egitto 3
GR - Grecia 3
LT - Lituania 3
MY - Malesia 3
PH - Filippine 3
PY - Paraguay 3
TT - Trinidad e Tobago 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
BJ - Benin 2
CZ - Repubblica Ceca 2
HN - Honduras 2
IL - Israele 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LV - Lettonia 2
PE - Perù 2
PK - Pakistan 2
PT - Portogallo 2
SV - El Salvador 2
TH - Thailandia 2
VE - Venezuela 2
AO - Angola 1
AT - Austria 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
CH - Svizzera 1
GD - Grenada 1
GE - Georgia 1
HR - Croazia 1
IR - Iran 1
JM - Giamaica 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
RS - Serbia 1
SI - Slovenia 1
TJ - Tagikistan 1
TL - Timor Orientale 1
VC - Saint Vincent e Grenadine 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.922
Salva come PNG Salva come JPEG
Città #
Santa Clara 538
Singapore 364
Ashburn 285
Hefei 222
Hong Kong 194
Seoul 167
San Jose 132
Dublin 81
Chandler 80
Milan 50
Munich 50
Beijing 47
Los Angeles 47
New York 38
Ho Chi Minh City 31
Paris 30
Kent 29
Lauterbourg 27
Buffalo 26
Council Bluffs 25
Moscow 23
Melbourne 22
Hanoi 21
Florence 20
Turku 19
Phoenix 17
São Paulo 17
The Dalles 17
Helsinki 16
Rome 16
Shanghai 16
Dallas 15
West Jordan 15
Bengaluru 14
Chicago 14
Montreal 13
Jakarta 12
Brooklyn 11
Boston 10
Naples 10
Orem 10
Frankfurt am Main 9
Lappeenranta 9
London 9
Mumbai 8
Abuja 7
Toronto 7
Altamura 6
Brescia 6
Cascina 6
Da Nang 6
Lawrence 6
Seattle 6
Tampa 6
Tokyo 6
Warsaw 6
Atlanta 5
Baghdad 5
Guangzhou 5
Haiphong 5
Pune 5
Stockholm 5
Wilmington 5
Yubileyny 5
Biên Hòa 4
Boardman 4
Bologna 4
Fairfield 4
Guayaquil 4
Johannesburg 4
Lucca 4
Newark 4
Palermo 4
Porto Alegre 4
Princeton 4
Southwark 4
Thái Bình 4
Tripoli 4
Abidjan 3
Anacortes 3
Belo Horizonte 3
Chennai 3
Dagenham 3
Denver 3
Garden City 3
Houston 3
Maldonado 3
New Delhi 3
Ninh Bình 3
Philadelphia 3
Pontedera 3
Richmond 3
San Diego 3
San Francisco 3
Skikda 3
Tashkent 3
Tunis 3
Turin 3
Washington 3
Wuhan 3
Totale 3.056
Salva come PNG Salva come JPEG
Nome #
Stereotactic radiotherapy in oligoprogressive and oligorecurrent urothelial cancer patients: A retrospective experience 200
Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patients 196
Stereotactic body radiation therapy (SBRT) on renal cell carcinoma, an overview of technical aspects, biological rationale and current literature 196
Accelerated hypofractionated radiation for elderly or frail patients with a newly diagnosed glioblastoma: A pooled analysis of patient-level data from 4 prospective trials 189
Pleomorphic Xanthoastrocytoma: a single institution retrospective analysis and a review of the literature 184
Regorafenib in glioblastoma recurrence: A case report 184
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results 183
Three Months' PSA and Toxicity from a Prospective Trial Investigating STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence after Prostatectomy-STARR (NCT05455736) 179
Stereotactic or conventional radiotherapy for macroscopic prostate bed recurrence: a propensity score analysis 178
Radiotherapy for elderly patients with glioblastoma: an assessment of hypofractionation and modern treatment techniques 177
Modulation of tumor-associated macrophage activity with radiation therapy: a systematic review 175
Predictive factors for tolerance to taxane based chemotherapy in older adults affected by metastatic prostate cancer (ANCHISES-NCT05471427): A prospective observational trial including patients with metastatic hormone sensitive and castrate resistant prostate cancer treated with taxane chemotherapy 174
Stereotactic Re-irradiation in Recurrent Prostate Cancer after Previous Postoperative or Definitive Radiotherapy: Long-term Results after a Median Follow-up of 4 Years 174
PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT within a prospective study 172
Prospective assessment of AR splice variant and multi-biomarker expression on circulating tumor cells of mCRPC patients undergoing androgen receptor targeted agents: interim analysis of PRIMERA trial (NCT04188275) 168
Local treatment for relapsing glioblastoma: A decision-making tree for choosing between reirradiation and second surgery 167
Study protocol and preliminary results from a mono-centric cohort within a trial testing stereotactic body radiotherapy and abiraterone (ARTO-NCT03449719) 165
Pattern of Recurrence After Stereotactic Radiotherapy in Prostate Cancer Patients With Nodal Pelvic Relapse. A Multi-Institutional Retrospective Analysis 164
Prospective assessment of AR splice variant and PSMA detection on circulating tumor cells of mCRPC patients: preliminary analysis of patients enrolled in PRIMERA trial (NCT04188275) 161
PERSIAN trial (NCT05717660): an ongoing randomized trial testing androgen deprivation therapy, apalutamide and stereotactic body radiotherapy. An alternative "triplet" for oligometastatic hormone sensitive prostate cancer patients 150
Single-fraction stereotactic body radiotherapy for oligometastatic lymph node relapse in prostate cancer 148
Integrating stereotactic body radiation therapy (SBRT) and systemic treatments in oligoprogressive prostate cancer: new evidence from the literature 148
Impact of stereotactic body radiotherapy vs palliative radiotherapy on oncologic outcomes of patients with metastatic kidney cancer concomitantly treated with immune checkpoint inhibitors: a preliminary, multicentre experience 146
May Different Treatment Volumes and Technical Approaches Have an Impact on Second Malignancies Risk? 144
Antiangiogenic drugs as chemosensitizer in genitourinary cancer 142
Synchronous bilateral testicular germ cell tumour: Case report and review of the literature 136
Dose-escalated pelvic radiotherapy for prostate cancer in definitive or postoperative setting 131
Antiangiogenic drugs as chemosensitizer in renal cell cancer 122
Killing two birds with a stone: how to maximise benefit from metastasis-directed therapy and modern systemic treatment in oligometastatic hormone sensitive prostate cancer 120
Stereotactic reirradiation with CyberknifeR for locally recurrent prostate cancer, long-term toxicity and clinical outcomes from a monocentric cohort 119
Significant interruptions in radiotherapy during curative treatment for prostate cancer are correlated with poorer oncological outcomes 51
Totale 4.943
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.575
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.575
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202239 0 0 0 15 3 0 0 4 1 1 6 9
2022/2023330 10 27 8 18 35 80 53 25 60 1 5 8
2023/2024273 11 19 26 21 14 43 17 67 2 22 18 13
2024/20251.819 43 142 92 252 445 245 28 125 88 79 107 173
2025/20262.262 271 352 352 231 206 59 244 98 108 115 86 140
2026/2027220 63 44 113 0 0 0 0 0 0 0 0 0
Totale 4.943